(UROY) Uranium Royalty - Overview
Sector: Energy | Industry: Uranium | Exchange: NASDAQ (USA) | Market Cap: 501m USD | Total Return: 44.6% in 12m
Avg Turnover: 8.48M
Qual. Beats: 3
Rev. Trend: 21.8%
Warnings
P/E ratio 113.8
Volatile Below Avwap Earnings
Tailwinds
No distinct edge detected
Uranium Royalty Corp. (UROY) is a Vancouver-based firm focused on the acquisition and management of uranium-related assets across North America, Africa, and Europe. Its business model centers on building a diversified portfolio of royalties, equity investments in uranium miners, and the direct ownership of physical uranium inventory. Unlike mining operators, royalty companies provide upfront capital to producers in exchange for a percentage of future production or revenue, reducing direct exposure to operational mining costs.
The company operates within a sector driven by global decarbonization efforts and the increasing role of nuclear power in baseload electricity generation. By maintaining physical uranium holdings, the company captures direct price appreciation in the spot market while its royalty interests provide long-term leverage to mine development and production. Investors looking for deeper fundamental analysis may find further insights on ValueRay.
- Spot uranium price fluctuations directly impact physical inventory valuation and royalty revenue
- Global nuclear energy expansion accelerates demand for long-term supply contracts
- Strategic physical uranium holdings provide immediate leverage to commodity spot price gains
- Development progress at world-class royalty assets like McClean Lake drives future cash flow
- Geopolitical shifts toward energy independence increase valuation of North American uranium assets
| Net Income: 4.39m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 26.86 > 1.0 |
| NWC/Revenue: 592.8% < 20% (prev 1.03k%; Δ -436.9% < -1%) |
| CFO/TA 0.11 > 3% & CFO 41.6m > Net Income 4.39m |
| Net Debt (-138.9m) to EBITDA (5.26m): -26.40 < 3 |
| Current Ratio: 325.3 > 1.5 & < 3 |
| Outstanding Shares: last quarter (142.1m) vs 12m ago 8.47% < -2% |
| Gross Margin: 17.72% > 18% (prev 0.31%; Δ 1.74k% > 0.5%) |
| Asset Turnover: 16.03% > 50% (prev 7.75%; Δ 8.28% > 0%) |
| Interest Coverage Ratio: 317.2 > 6 (EBITDA TTM 5.26m / Interest Expense TTM 16.0k) |
| A: 0.85 (Total Current Assets 324.8m - Total Current Liabilities 999k) / Total Assets 383.0m |
| B: 0.06 (Retained Earnings 22.8m / Total Assets 383.0m) |
| C: 0.01 (EBIT TTM 5.08m / Avg Total Assets 340.8m) |
| D: 272.2 (Book Value of Equity 381.6m / Total Liabilities 1.40m) |
| Altman-Z'' = 291.6 = AAA |
| DSRI: 0.01 (Receivables 8.01k/596k, Revenue 54.6m/23.1m) |
| GMI: 1.76 (GM 17.72% / 31.28%) |
| AQI: 0.77 (AQ_t 0.15 / AQ_t-1 0.20) |
| SGI: 2.36 (Revenue 54.6m / 23.1m) |
| TATA: -0.10 (NI 4.39m - CFO 41.6m) / TA 383.0m) |
| Beneish M = -2.41 (Cap -4..+1) = BBB |
As of May 24, 2026, the stock is trading at USD 3.48 with a total of 2,365,300 shares traded.
Over the past week, the price has changed by -10.13%,
over one month by -9.89%,
over three months by -19.57% and
over the past year by +44.64%.
Uranium Royalty has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy UROY.
- StrongBuy: 2
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 4.5 | 28.7% |
P/E Trailing = 113.8333
P/E Forward = 17.2414
P/S = 9.1686
P/B = 1.8237
Revenue TTM = 54.6m CAD
EBIT TTM = 5.08m CAD
EBITDA TTM = 5.26m CAD
Long Term Debt = 109k CAD (estimated: total debt 168k - short term 59.1k)
Short Term Debt = 59.1k CAD (from shortTermDebt, last quarter)
Debt = 168k CAD (from shortLongTermDebtTotal, last quarter) (leases 168k already included)
Net Debt = -138.9m CAD (calculated: Debt 168k - CCE 139.1m)
Enterprise Value = 549.3m CAD (688.2m + Debt 168k - CCE 139.1m)
Interest Coverage Ratio = 317.2 (Ebit TTM 5.08m / Interest Expense TTM 16.0k)
EV/FCF = 13.54x (Enterprise Value 549.3m / FCF TTM 40.6m)
FCF Yield = 7.39% (FCF TTM 40.6m / Enterprise Value 549.3m)
FCF Margin = 74.28% (FCF TTM 40.6m / Revenue TTM 54.6m)
Net Margin = 8.03% (Net Income TTM 4.39m / Revenue TTM 54.6m)
Gross Margin = 17.72% ((Revenue TTM 54.6m - Cost of Revenue TTM 44.9m) / Revenue TTM)
Gross Margin QoQ = 25.10% (prev 29.27%)
Tobins Q-Ratio = 1.43 (Enterprise Value 549.3m / Total Assets 383.0m)
Interest Expense / Debt = 9.51% (Interest Expense 16.0k / Debt 168k)
Taxrate = 21.0% (US default 21%)
NOPAT = 4.01m (EBIT 5.08m * (1 - 21.00%))
Current Ratio = 325.3 (out of range, set to none) (Total Current Assets 324.8m / Total Current Liabilities 999k)
Debt / Equity = 0.00 (Debt 168k / totalStockholderEquity, last quarter 381.6m)
Debt / EBITDA = -26.40 (Net Debt -138.9m / EBITDA 5.26m)
Debt / FCF = -3.42 (Net Debt -138.9m / FCF TTM 40.6m)
Total Stockholder Equity = 326.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.29% (Net Income 4.39m / Total Assets 383.0m)
RoE = 1.35% (Net Income TTM 4.39m / Total Stockholder Equity 326.0m)
RoCE = 1.56% (EBIT 5.08m / Capital Employed (Equity 326.0m + L.T.Debt 109k))
RoIC = 1.05% (NOPAT 4.01m / Invested Capital 382.1m)
WACC = 12.14% (E(688.2m)/V(688.4m) * Re(12.14%) + D(168k)/V(688.4m) * Rd(9.51%) * (1-Tc(0.21)))
Discount Rate = 12.14% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 95.56 | Cagr: 12.11%
[DCF] Terminal Value 63.38% ; FCFF base≈40.6m ; Y1≈40.7m ; Y5≈43.2m
[DCF] Fair Price = 3.73 (EV 408.4m - Net Debt -138.9m = Equity 547.3m / Shares 146.6m; r=12.14% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 1.38 | # QB: 3
Revenue Correlation: 21.80 | Revenue CAGR: 12.67% | SUE: N/A | # QB: 0